| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Aztreonam measurement |
Component |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Monobactam adverse reaction (disorder) |
Causative agent (attribute) |
False |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aztreonam adverse reaction |
Causative agent (attribute) |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aztreonam allergy |
Causative agent (attribute) |
False |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aztreonam 500 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aztreonam 1 g powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aztreonam-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aztreonam 20mg/mL injection solution 50mL plastic container |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aztreonam 40mg/mL injection solution 50mL plastic container |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aztreonam 75mg powder for nebulizer solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aztreonam allergy |
Causative agent (attribute) |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aztreonam lysine (substance) |
Is a |
False |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aztreonam 500 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aztreonam 500 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aztreonam 1 g powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aztreonam 1 g powder for solution for injection vial |
Has precise active ingredient |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aztreonam lysine (substance) |
Is modification of (attribute) |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aztreonam-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aztreonam only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aztreonam only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aztreonam 75 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
Has precise active ingredient |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aztreonam 75 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aztreonam only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing aztreonam in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aztreonam 1 g powder for solution for infusion and/or injection vial |
Has precise active ingredient |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aztreonam 1 g powder for solution for infusion and/or injection vial |
Has basis of strength substance (attribute) |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has precise active ingredient |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aztreonam (as aztreonam lysine) 75 mg powder for inhalation solution vial |
Has basis of strength substance (attribute) |
True |
Aztreonam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]